Document:

Ex. 10.23
                               NUWAY MEDICAL, INC.
                                 PROMISSORY NOTE

U.S. $65,000                                            Dated: November 20, 2003

FOR VALUE RECEIVED, the undersigned, NuWay Medical, Inc., a Delaware corporation
(the "Company"), HEREBY UNCONDITIONALLY PROMISES TO PAY to the order of James
Seay, DDS, an Individual (the "Holder"), the principal sum of SIXTY FIVE
THOUSAND UNITED STATES DOLLARS (U.S. $65,000) in accordance with the payment
schedule set forth in Section 2.1.

      1. INTEREST. This Promissory Note (this "Note") shall bear no interest.

      2. PAYMENT.

            2.1 PAYMENT SCHEDULE. The principal shall be payable in one payment
due on the 90th day (the "Maturity Date") after fifty thousand United State
dollars (U.S. $50,000) is paid to the Company by the Holder, or the Holder's
predecessor(s) in interest, except to the extent prepayment must be made under
Section 3.

            2.2 PAYMENT LOCATION. Payment of the principal is to be made at the
main office of the Holder, or at such other place as the Holder shall designate
to the Company in writing, in lawful money of the United States of America.

            2.3 BUSINESS DAYS. Whenever any payment hereunder shall be stated to
be due or any other date specified hereunder would otherwise occur, on a day
other than a Business Day (as defined below), then, except as otherwise provided
herein, such payment shall be made or other date shall occur, on the next
succeeding Business Day. As used herein, "Business Day" means a day (i) other
than Saturday or Sunday, and (ii) on which commercial banks are open for
business in Orange County, California.

      3. PREPAYMENT. The Company must prepay principal outstanding hereunder to
the extent, prior to the Maturity Date, the Company receives cash proceeds equal
to or exceeding two hundred thousand United States dollars (U.S. $200,000) with
respect to or in connection with the letter of intent entered into by the
Company with CVD International, Inc. in which certain investors are to provide a
bridge loan to the Company in the amount of $250,000 to $500,000 ("Prepayment
Trigger"). On each occurrence of a Prepayment Trigger prior to the Maturity
Date, the Company must prepay principal hereunder in an amount equal to the net
cash proceeds received by the Company from the Prepayment Trigger after
deducting all expenses associated therewith up to the Company's obligation
pursuant to this Note.

      4. EVENTS OF DEFAULT.

            4.1 Any of the following events which shall occur shall constitute
an "Event of Default":

                  (a) The Company shall fail to pay when due any amount of
principal hereunder or other amount payable hereunder.

                  (b) The Company shall fail to perform or observe any other
term, covenant or agreement contained in this Note on its part to be performed
or observed and any such failure shall remain unremedied for a period of 60 days
from the occurrence thereof.

<PAGE>

                  (c) The Company shall admit in writing its inability to, or
shall fail generally or be generally unable to, pay its debts (including its
payrolls) as such debts become due, or shall make a general assignment for the
benefit of creditors; or the Company shall file a voluntary petition in
bankruptcy or a petition or answer seeking reorganization, to effect a plan or
other arrangement with creditors or any other relief under the Bankruptcy Reform
Act of 1978, as amended or recodified from time to time (the "Bankruptcy Code");
or an involuntary petition seeking any of the relief specified in this paragraph
shall be filed against the Company and shall not be dismissed within 90 days.

                  (d) The Company shall (i) liquidate, wind up or dissolve (or
suffer any liquidation, wind-up or dissolution), or (ii) suspend its operations
other than in the ordinary course of business.

            4.2 If any Event of Default shall occur, the Holder may (i) by
notice to the Company, declare the entire unpaid principal amount of this Note
to be forthwith due and payable, whereupon all unpaid principal under this Note
shall become and be forthwith due and payable, without presentment, demand,
protest or further notice of any kind, all of which are hereby expressly waived
by the Company; and (ii) whether or not the actions referred to in clause (i)
have been taken, proceed to enforce all other rights and remedies available to
the Holder under applicable law.

      5. MISCELLANEOUS.

            5.1 NOTICES. All notices, requests, demands, and other
communications under this Note shall be in writing and shall be deemed to have
been duly given on the date of service if served personally on the party to whom
notice is to be given, or on the third day after mailing if mailed to the party
to whom notice is to be given, by first class mail, registered or certified,
postage prepaid, and properly addressed as follows:

          To the Holder:

          To the Company:                   NuWay Medical, Inc.
                                            23461 South Pointe Drive, Suite 200
                                            Laguna Hills, CA 92653
                                            Attn: President

Any party may change his or its address for purposes of this paragraph by giving
notice of the new address to each of the other parties in the manner set forth
above.

            5.2 DELAY. No failure on the part of the Holder to exercise, and no
delay in exercising, any right, remedy, power or privilege hereunder shall
operate as a waiver thereof, nor shall any single or partial exercise of any
such right, remedy, power or privilege preclude any other or further exercise
thereof or the exercise of any other right, remedy, power or privilege. The
rights and remedies under this Note are cumulative and not exclusive of any
rights, remedies, powers and privileges that may otherwise be available to the
Holder.

            5.3 Severability. Whenever possible, each provision of this Note
shall be interpreted in such manner as to be effective and valid under all
applicable laws and regulations. If, however, any provision of this Note shall
be prohibited by or invalid under any such law or regulation in any

                                       2
<PAGE>

jurisdiction, it shall, as to such jurisdiction, be deemed modified to conform
to the minimum requirements of such law or regulation, or, if for any reason it
is not deemed so modified, it shall be ineffective and invalid only to the
extent of such prohibition or invalidity without affecting the remaining
provisions of this Note, or the validity or effectiveness of such provision in
any other jurisdiction.

            5.4 Successors and Assigns. This Note shall be binding upon, inure
to the benefit of and be enforceable by the Company, the Holder and their
respective successors and assigns.

            5.5 Headings. The subject headings of the Articles and Sections of
this Note are included for purposes of convenience only, and shall not affect
the construction or interpretation of any of its provisions.

      IN WITNESS WHEREOF, the Company has duly executed this Note, as of the
date first above written.

                             NUWAY MEDICAL, INC., a
                             Delaware corporation

                                /s/
                             -----------------------------
                             Dennis Calvert
                             Chief Executive Officer

                                       3AMENDMENT NO. 1
                                       TO
                               TERM LOAN AGREEMENT

         This AMENDMENT NO. 1 TO TERM LOAN AGREEMENT (this "Amendment") is dated
to be effective as of March 30, 2004 and is entered into between NUWAY MEDICAL,
INC., a corporation organized under the laws of the state of Delaware (the
"Borrower"), and AUGUSTINE II, LLC, a limited liability company formed under the
laws of the State of Delaware (the "Lender").

                                   BACKGROUND:

         Borrower and Lender are parties to that certain Term Loan Agreement
dated as of June 10, 2003 (the "Agreement"). Pursuant to the Agreement, Borrower
and Lender have also entered into that certain Pledge Agreement, and Borrower
previously has delivered to Lender a Term Note and Warrant to Purchase Common
Stock No. AG-1 (the "Warrant"), each dated as of June 10, 2003 (the Agreement,
together with such Pledge Agreement, Term Note and Warrant, the "Loan
Documents"). Borrower has requested that Lender extend the maturity date of the
term loan evidenced by the Loan Documents, and in consideration of Lender's
willingness to do so has agreed to reprice the Warrant.

         Capitalized terms used herein shall have the meanings ascribed to such
terms in Section 8 of the Agreement.

         NOW THEREFORE, in consideration of the foregoing and for other good and
valuable consideration, the receipt and sufficiency of which is hereby
acknowledged:

         1. Extension of Maturity Date. The Term Loan Maturity Date is hereby
extended to August 31, 2004, and the last sentence of Section 1.2 of the
Agreement is amended accordingly.

         2. Remedies Upon Default. Section 7.2 of the Agreement is hereby
amended and restated in its entirety to read as follows:

         SECTION 7.2       REMEDIES.

                  (a) Upon the occurrence of any Event of Default set forth in
         subsections (a)-(k) of Section 7.1 and during the continuance thereof,
         the Lender or any other holder of the Term Note may declare the Term
         Note and any other amounts owed to the Lender to be immediately due and
         payable, whereupon the Term Note and any other amounts owed to the
         Lender shall forthwith become due and payable. Upon the occurrence of
         any Event of Default set forth in subsection (l) of Section 7.1, the
         Term Note and any other amounts owed to the Lender shall be immediately
         and automatically due and payable without action of any kind on the
         part of the Lender or any other holder of the Term Note. The Borrower
         expressly waives presentment, demand, notice or protest of any kind in

<PAGE>

         connection herewith. The Lender shall promptly give the Borrower notice
         of any such declaration, but failure to do so shall not impair the
         effect of such declaration. No delay or omission on the part of the
         Lender or any holder of the Term Note in exercising any power or right
         hereunder or under the Term Note shall impair such right or power or be
         construed to be a waiver of any Event of Default or any acquiescence
         therein, nor shall any single or partial exercise of any power or right
         hereunder preclude other or further exercise thereof, or the exercise
         of any other power or right.

                  (b) Upon and during the continuance of any Event of Default
         the Lender may exercise any and all remedies available to it under this
         Agreement or the Pledge Agreement, at law or in equity, or by statute
         or otherwise, including (a) exercise any rights of a secured lender
         under the UCC and/or any other applicable Uniform Commercial Code, and
         (b) conversion of the Term Note into Common Stock of the Company as
         provided therein.

                  (c) The enumeration of Lender's rights and remedies set forth
         in this Agreement is not intended to be exhaustive. The exercise by
         Lender of any right or remedy under this Agreement or any other
         agreement or instrument executed and delivered in furtherance of the
         transactions contemplated by this Agreement does not preclude the
         exercise of any other rights or remedies, however existing.

         3. AMENDED NOTE. The Term Note shall be replaced by an Amended and
Restated Term Note in the form attached hereto as Exhibit A (the "Amended
Note"), and upon delivery of the executed Amended Note to Lender, Lender shall
deliver the existing Term Note to Borrower. Thereafter, all references in the
Agreement to "Term Note" shall be deemed to be references to the Amended Note.

         4. AMENDED WARRANT. The Warrant shall be replaced by an Amended and
Restated Warrant in the form attached hereto as Exhibit B (the "Amended
Warrant"), and upon delivery of the executed Amended Warrant to Lender, Lender
shall deliver the existing Warrant to Borrower. Thereafter, all references in
the Agreement to "Warrant" shall be deemed to be references to the Amended
Warrant.

         5. REPRESENTATIONS, WARRANTIES AND COVENANTS.

                  (a) The representations of Borrower in the Agreement and the
          other Loan Documents,  as amended  hereby,  are true and correct as of
          the date hereof as though each of said  representations and warranties
          was made on the date  hereof  except  for  those  representations  and
          warranties  which are made as of a  specified  date in the  applicable
          Loan Document.

                  (b) The parties acknowledge that, as of the date of this
          Amendment,  Borrower  does not have  sufficient  number  of  shares of
          authorized  Common  Stock to issue upon full  exercise  of the Warrant
          and/or full  conversion of the Amended Note.  Borrower  represents and
          warrants  to Lender that  effective  February  11,  2004  shareholders
          holding a majority of the issued and outstanding Common Stock approved
          an  amendment  to  Borrower's  articles  of  incorporation  that would

<PAGE>

          increase the total number of  authorized  shares to  200,000,000  (the
          "Charter Amendment"). Borrower covenants to Lender that:

                  (i) Borrower shall cause the Charter Amendment to become
         effective no later than August 31, 2004;

                  (ii) Borrower has, by resolution of its Board of Directors
         dated February 4, 2004, reserved all [13,000,000] shares of Common
         Stock that currently are authorized but unissued for issuance upon
         exercise of the Warrant and/or conversion of the Amended Note;

                  (iii) Beginning immediately after the Charter Amendment
         becomes effective, Borrower shall at all times reserve and keep
         available for issuance such number of shares of authorized but unissued
         Common Stock as will be sufficient to permit the exercise in full of
         the Warrant and the conversion in full of the Amended Note; and

                  (iv) Any failure by Borrower to observe the foregoing
         covenants shall be an "Event of Default" under the Agreement.

         6. ADDITIONAL COVENANT OF LENDER. Lender agrees that, at any time
during which the Amended Note is outstanding and until the Amended Note has been
repaid, converted, or otherwise satisfied in full, it will not engage in hedging
transactions (including without limitation any short sales) with respect to the
Common Stock.

         7. AMENDMENT SUPPLEMENTARY. This Amendment is supplementary to the Loan
Documents. All of the provisions of the Loan Documents, including without
limitation the right to declare principal and accrued interest due for any cause
specified in the Loan Documents, shall remain in full force and effect except as
herein expressly modified. The Agreement and the other Loan Documents and all
rights and powers created thereby and thereunder or under such other documents
are in all respects ratified and confirmed. From and after the date hereof, the
Agreement and the other Loan Documents shall be deemed to be amended and
modified as herein provided, but, except as so amended and modified, the
Agreement and the other Loan Documents shall continue in full force and effect
and the Agreement, the other Loan Documents, and this Amendment shall be read,
taken and construed as one and the same instrument. On and after the date
hereof, any references in the Loan Documents to the Agreement shall mean the
Agreement as amended hereby.

         8. WAIVER OF CLAIMS. Borrower hereby acknowledges, agrees and affirms
that it possesses no claims, defenses, offsets, recoupment or counterclaims of
any kind or nature against or with respect to the enforcement of the Agreement,
or any other Loan Document or any amendments thereto (collectively, the
"Claims"), nor does Borrower now have knowledge of any facts that would or might
give rise to any Claims. If facts exist as of the date of this Amendment which
would or could give rise to any Claim against or with respect to the enforcement
of the Agreement, or any other Loan Document, as amended by the amendments
thereto, Borrower hereby unconditionally, irrevocably and unequivocally waives
and fully releases any and all such Claims as if such Claims were the subject of

<PAGE>

a lawsuit, adjudicated to final judgment from which no appeal could be taken and
therein dismissed with prejudice. In furtherance of the intention of the
parties, Borrower hereby expressly waives any and all rights conferred upon it
by the provisions of any applicable law which would provide that "A general
release does not extend to claims which the creditor does not know or suspect to
EXIST in his favor at the time of executing the release which, if known by him,
must have materially affected his settlement with the debtor." Borrower hereby
understands and acknowledges the significance and consequences of the foregoing
release and waiver.

         9. Representation by Counsel. Borrower hereby represents that it has
been represented by competent counsel of its choice in the negotiation and
execution of this Amendment; that it has read and fully understands the terms
hereof, that Borrower and its counsel have been afforded an opportunity to
review, negotiate and modify the terms of this Amendment, and that it intends to
be bound hereby.

         10. Counterparts. This Agreement may be executed in one or more
counterparts, which counterparts, when taken together and collated shall
constitute one agreement.

         IN WITNESS WHEREOF, the parties have caused this Agreement to be duly
executed as of the day and year first above written.

                                      NUWAY MEDICAL, INC.

                                       /s/
                                      By:
                                         --------------------------------------

                                      Its:  President

                                      AUGUSTINE II, LLC

                                      By:      AUGUSTINE CAPITAL
                                               MANAGEMENT, L.L.C., its
                                               manager

                                          /s/
                                      By:
                                         --------------------------------------

                                      Its:
                                          -------------------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00074-of-00352.parquet"}]]